Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Pharma veteran Ciaffoni to take CEO reins at Indivior
(Sharecast News) - Indivior announced the appointment of Joe Ciaffoni as its next chief executive officer on Thursday, subject to shareholder approval of a new remuneration policy at its annual general meeting in May. The addiction treatment specialist said Ciaffoni, who joined the board as an independent non-executive director in December, would succeed Mark Crossley, who was stepping down after nearly five years in the role.
It said Ciaffoni would bring more than 30 years of experience in the pharmaceutical and biotech sectors, having previously served as president and CEO of Collegium Pharmaceutical.
His career included senior roles at Endo International, Biogen and Shionogi, where he had worked across a range of therapeutic areas, including specialty and rare diseases.
Crossley, who has led Indivior since June 2020, would remain with the company to support the leadership transition and was expected to serve as chief executive until at least the AGM.
"We are delighted to appoint Joe as our next chief executive officer," said chair David Wheadon.
"He is an accomplished leader with a strong track record of delivering positive outcomes for patients while generating shareholder value.
"He has a clear mandate to fuel the next stage of Indivior's growth and deliver on the company's significant potential and we look forward to supporting his success as CEO."
At 0952 GMT, shares in Indivior were up 0.46% at 654p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
